Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy.
Saved in:
| Title: | Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy. |
|---|---|
| Authors: | Zhang Z; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA. ze.zhang.gr@dartmouth.edu.; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. ze.zhang.gr@dartmouth.edu., Sehgal K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shirai K; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Butler RA; Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA., Wiencke JK; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA., Koestler DC; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA., Ramush G; Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA., Lee MK; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.; Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA., Molinaro AM; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Stolrow HG; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA., Birnbaum A; Department of Medicine, Rhode Island Hospital, Providence, RI, USA., Salas LA; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.; Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kelsey KT; Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA.; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA., Christensen BC; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA.; Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.; Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, NH, USA. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2024 Nov 18; Vol. 8 (1), pp. 267. Date of Electronic Publication: 2024 Nov 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-024-00759-8 |
